Managing concomitant cardiac disease and erectile dysfunction

Reviews in Urology
|September 21, 2006
PubMed

Insights

Sexual activity poses minimal cardiovascular risk, even for patients with a history of myocardial infarction (MI). Guidelines help physicians assess risks for erectile dysfunction (ED) patients with cardiovascular disease (CAD), ensuring safe management.

Area of Science:

  • Cardiology
  • Sexual Medicine
  • Cardiovascular Disease Management

Background:

  • Early beliefs suggested sexual activity posed significant cardiovascular risk.
  • Subsequent research indicates heart rates during coitus are comparable to physical exercise or anger.
  • Coronary artery disease (CAD) is strongly linked to erectile dysfunction (ED), sharing similar risk factors.

Purpose of the Study:

  • To re-evaluate the cardiovascular risks associated with sexual activity in patients with cardiovascular disease.
  • To assess the safety and efficacy of sildenafil citrate in patients with cardiovascular disease and erectile dysfunction.
  • To provide guidance on risk stratification for patients with ED and cardiovascular disease.

Main Methods:

  • Review of early and subsequent studies on cardiovascular responses during coitus.
  • Analysis of the absolute and relative risk of myocardial infarction (MI) following sexual activity.
  • Examination of studies evaluating sildenafil citrate use in patients with cardiovascular disease.
  • Reference to clinical guidelines for risk classification of patients with ED and cardiovascular disease.

Main Results:

  • The absolute risk of MI during coitus is low (10 per million per hour), with a negligible impact on annual risk even when doubled post-coitus.
  • Sildenafil citrate is safe and effective for treating ED in patients with cardiovascular disease, with the sole contraindication being concurrent nitrate use.
  • Clinical guidelines allow for risk stratification of patients with ED and cardiovascular disease into low, intermediate, or indeterminate risk categories.

Conclusions:

  • Sexual activity is generally safe for most patients with cardiovascular disease.
  • Physicians should utilize established guidelines to manage patients with ED and cardiovascular disease, differentiating risk levels.
  • Sildenafil can be prescribed cautiously, avoiding concomitant use with nitrates, to manage ED in this population.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...